Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Down 14.6% in September

Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report) was the recipient of a large decrease in short interest in September. As of September 15th, there was short interest totalling 56,000 shares, a decrease of 14.6% from the August 31st total of 65,600 shares. Based on an average daily trading volume, of 10,900 shares, the days-to-cover ratio [...]

featured-image

Check-Cap Ltd. ( NASDAQ:CHEK – Get Free Report ) was the recipient of a large decrease in short interest in September. As of September 15th, there was short interest totalling 56,000 shares, a decrease of 14.

6% from the August 31st total of 65,600 shares. Based on an average daily trading volume, of 10,900 shares, the days-to-cover ratio is presently 5.1 days.



Approximately 1.3% of the company’s shares are short sold. Check-Cap Price Performance Shares of CHEK stock traded down $0.

18 during trading hours on Friday, reaching $1.17. The company had a trading volume of 59,468 shares, compared to its average volume of 96,044.

The company has a 50 day moving average of $1.85 and a 200 day moving average of $2.09.

The firm has a market cap of $6.87 million, a price-to-earnings ratio of -0.39 and a beta of 0.

39. Check-Cap has a 1-year low of $1.13 and a 1-year high of $4.

59. Wall Street Analysts Forecast Growth Separately, StockNews.com began coverage on Check-Cap in a report on Sunday, September 22nd.

They set a “sell” rating on the stock. About Check-Cap ( Get Free Report ) Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.

Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. See Also Five stocks we like better than Check-Cap Investing in the High PE Growth Stocks Simon Property REIT: A Safe Bet for Growth and Steady Dividends 3 Home Improvement Stocks that Can Upgrade Your Portfolio CarMax’s Impressive Rally: What Investors Should Watch Next Retail Stocks Investing, Explained MarketBeat Week in Review – 9/23 – 9/27 Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter .

.